BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26873992)

  • 1. Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
    Currie SM; Gwyer Findlay E; McFarlane AJ; Fitch PM; Böttcher B; Colegrave N; Paras A; Jozwik A; Chiu C; Schwarze J; Davidson DJ
    J Immunol; 2016 Mar; 196(6):2699-710. PubMed ID: 26873992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
    Currie SM; Findlay EG; McHugh BJ; Mackellar A; Man T; Macmillan D; Wang H; Fitch PM; Schwarze J; Davidson DJ
    PLoS One; 2013; 8(8):e73659. PubMed ID: 24023689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.
    Harcourt JL; McDonald M; Svoboda P; Pohl J; Tatti K; Haynes LM
    BMC Res Notes; 2016 Jan; 9():11. PubMed ID: 26732674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infection.
    Sintoris S; Binkowska JM; Gillan JL; Zuurbier RP; Twynam-Perkins J; Kristensen M; Melrose L; Parga PL; Rodriguez AR; Chu ML; van Boeckel SR; Wildenbeest JG; Bowdish DME; Currie AJ; Thwaites RS; Schwarze J; van Houten MA; Boardman JP; Cunningham S; Bogaert D; Davidson DJ
    Sci Rep; 2024 Jun; 14(1):13928. PubMed ID: 38886476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Role of the NF-κB Pathway in the
    Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
    Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
    PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.
    Hillyer P; Shepard R; Uehling M; Krenz M; Sheikh F; Thayer KR; Huang L; Yan L; Panda D; Luongo C; Buchholz UJ; Collins PL; Donnelly RP; Rabin RL
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection.
    Lee HC; Headley MB; Loo YM; Berlin A; Gale M; Debley JS; Lukacs NW; Ziegler SF
    J Allergy Clin Immunol; 2012 Nov; 130(5):1187-1196.e5. PubMed ID: 22981788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
    J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
    J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.
    High M; Cho HY; Marzec J; Wiltshire T; Verhein KC; Caballero MT; Acosta PL; Ciencewicki J; McCaw ZR; Kobzik L; Miller-DeGraff L; Gladwell W; Peden DB; Serra ME; Shi M; Weinberg C; Suzuki O; Wang X; Bell DA; Polack FP; Kleeberger SR
    EBioMedicine; 2016 Sep; 11():73-84. PubMed ID: 27554839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.
    Noh Y; Shim BS; Cheon IS; Rho S; Kim HJ; Choi Y; Kang CY; Chang J; Song MK; Kim JO
    Viral Immunol; 2013 Aug; 26(4):268-76. PubMed ID: 23869549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.
    Ascough S; Paterson S; Chiu C
    Front Immunol; 2018; 9():323. PubMed ID: 29552008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of ginseng extract against respiratory syncytial virus infection.
    Lee JS; Ko EJ; Hwang HS; Lee YN; Kwon YM; Kim MC; Kang SM
    Int J Mol Med; 2014 Jul; 34(1):183-90. PubMed ID: 24756136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
    J Virol; 2013 Sep; 87(18):10070-82. PubMed ID: 23843644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
    González-Sanz R; Mata M; Bermejo-Martín J; Álvarez A; Cortijo J; Melero JA; Martínez I
    J Virol; 2016 Jan; 90(7):3428-38. PubMed ID: 26763998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a neonatal mouse model to study respiratory syncytial virus infections.
    Cormier SA; You D; Honnegowda S
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1371-80. PubMed ID: 21133663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.